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Abstract
Background: Guidelines are often slowly adapted into clinical practice. However, actively supporting healthcare
professionals in evidence-based treatment may speed up guideline implementation. Danish low back pain (LBP)
guidelines focus on primary care treatment of LBP, to reduce referrals from primary care to secondary care. The
primary aim of this project was to reduce secondary care referral within 12 weeks by a multifaceted implementation
strategy (MuIS).
Methods: In a cluster randomised design, 189 general practices from the North Denmark Region were invited to
participate. Practices were randomised (1:1) and stratified by practice size to MuIS (28 practices) or a passive
implementation strategy (PaIS; 32 practices). Included were patients with LBP aged 18 to 65 years who were able
to complete questionnaires, had no serious underlying pathology, and were not pregnant. We developed a MuIS
including outreach visits, quality reports, and the STarT Back Tool for subgrouping patients with LBP. Both groups
were offered the usual dissemination of guidelines, guideline-concordant structuring of the medical record, and a
new referral opportunity for patients with psycho-social problems. In an intention-to-treat analysis, the primary
and secondary outcomes pertained to the patient, and a cost-effectiveness analysis was performed from a
healthcare sector perspective. Patients and the assessment of outcomes were blinded. Practices and caregivers
delivering the interventions were not blinded.
Results: Between January 2013 and July 2014, 60 practices were included, of which 54 practices (28 MuIS, 26 PaIS)
included 1101 patients (539 MuIS, 562 PaIS). Follow-up data for the primary outcome were available on 100 % of these
patients. Twenty-seven patients (5.0 %) in the MuIS group were referred to secondary care vs. 59 patients (10.5 %) in
the PaIS group. The adjusted odds ratio (AOR) was 0.52 [95 % CI 0.30 to 0.90; p = 0.020]. The MuIS was cost-saving
£−93.20 (£406.51 vs. £499.71 per patient) after 12 weeks. Conversely, the MuIS resulted in less satisfied patients
after 52 weeks (AOR 0.50 [95 % CI 0.31 to 0.81; p = 0.004]).
Conclusions: Using a MuIS changed general practice referral behaviour and was cost effective, but patients in
the MuIS group were less satisfied. This study supports the application of a MuIS when implementing guidelines.
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Background
Low back pain (LBP) is a major cause of disability and a
burden for patients. For example, in the UK, LBP and
neck pain are the leading causes of disability-adjusted life
years [1]. The precise aetiology underlying most cases of
LBP is unknown; however, biological, psychological, and
social factors may all be important [2–4]. Therefore, LBP
treatment may be complex, and enhancing healthcare pro-
fessionals’ opportunities and competences is important to
offer the best available treatment. Current evidence for
LBP treatment is synthesised in guidelines to assist general
practitioners (GPs) and other healthcare professionals in
treating LBP and guide referrals to secondary care and
supplementary treatment. However, the implementation
of guidelines into practice is often slow. Therefore, know-
ledge regarding how to support guideline implementation
is needed [5]. In 2012, a new LBP guideline was published
in the North Denmark Region which focused on the
roles and responsibilities of primary healthcare providers.
Treatment within the first 8 weeks of the initial consult-
ation for LBP was considered particularly important for
improving primary care, thereby reducing unnecessary re-
ferrals to secondary care and consequently minimising
healthcare costs [6]. Traditionally, regional guidelines have
been disseminated using mostly passive implementation
strategies, although passive diffusion of innovation is not
generally the recommended method to change clinical be-
haviour [7]. Rather, supporting GPs in the uptake of LBP
guidelines by multifaceted implementation strategies is
more likely to generate a change in clinical behaviour [8].
In this study, we investigated whether a multifaceted
implementation strategy (MuIS) was more effective in
changing general practice behaviour than a passive im-
plementation strategy (PaIS). The aim was to reduce
general practices’ referrals of LBP patients to secondary
healthcare within 12 weeks.
Methods
Study design and participants
This study was a two-armed, cluster randomised con-
trolled trial comparing MuIS and PaIS in the North
Denmark Region. The study protocol is published with
open access [9]. Interventions were delivered at the prac-
tice level. We based our allocation on cluster randomisa-
tion at the practice level instead of the practitioner level
because patients could be seen by different GPs and other
healthcare professionals at the same general practice. Gen-
eral practices in the North Denmark Region were eligible
for inclusion. The latest updated list of practices in the re-
gion was from October 2011. The 191 practices and 332
GPs on this list were considered eligible for inclusion. The
total number of patients in the region was 579,829 with
an average of 3035 listed patients per practice [10]. Ex-
cluded were practices participating in pre-testing the
intervention and practices without an electronic data cap-
ture module. Participating practices had a project module
installed in their electronic medical record system, and
GPs were encouraged to perform diagnostic coding during
consultations with LBP patients. The ICPC-2 diagnostic
codes L02, L03, L84, and L86 triggered a study-specific
pop-up in the electronic patient record. If a patient met
the inclusion criteria, the GP invited the patient to par-
ticipate; however, the GP could also choose not to in-
clude the patient in the study. If the patient accepted
participation, consent was given by filling in the project
pop-up. Patients consenting to participate were informed
that completing the questionnaire was not a requirement
for study participation, but they were encouraged to do so.
Patients could discontinue study participation at any time
and without any consequences for their treatment. The in-
clusion criteria were consulting a GP for LBP of any dur-
ation for the first time within 3 months, with or without
associated radiculopathy, and aged 18 to 65 years. The ex-
clusion criteria were pregnancy, insufficient language skills
to complete the questionnaires in Danish, and serious
underlying disease (e.g. signs of fracture, cauda equina
syndrome, malignancy, osteoporosis, or spinal inflamma-
tory arthritis). The serious underlying diseases were not
within the scope of this study, as referral of patients with
these conditions is generally considered appropriate.
Randomisation and blinding
Practices were randomised 1:1 to the MuIS or PaIS. Prac-
tices were stratified by list size (≤2000 patients; 2001 to
5000 patients, or >5000 patients) in random permuted
blocks of two, four, and six. Randomisation was performed
by the statistical group at Aalborg University Hospital
using Stata (SE version 11.2, College Station, TX, USA)
with the Stata module RALLOC to generate the allocation
sequence. After a practice signed up for participation, the
coordinating secretary or the secretary’s assistant assigned
it a participation number and opened the corresponding
sealed envelope with the allocation information. The enve-
lopes were kept at the secretary’s office, and information
regarding the allocation sequence was kept in a locked
safe-box until the analysis was finished. The analysis group
(AR, CEJ, and MDB) was blinded to the allocation status.
Patients knew that they were participating in a study, but
they were not informed of their allocation status. Alloca-
tion was not blinded for the general practice personnel,
the outreach visitors, the researcher (MBJ) guiding the
outreach visitors, and other technical staff in contact with
the practices and outreach visitors, but they were all in-
formed that the analysis group was blinded.
Procedures
The MuIS practices and the PaIS practices were of-
fered usual implementation activities, which included
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an invitation to a regional information meeting about
the guidelines, information about the guidelines described
in a newsletter from The Quality Unit for General Practice
in the North Denmark Region, and the opportunity to
learn about the new guidelines with peers as part of the
GPs’ continuing medical education. Furthermore, all prac-
tices were offered project-related passive activities, which
included a referral opportunity for patients with psycho-
social problems, guideline-concordant structured compu-
terised medical record pop-ups, financial incentives to
participate, and reminders about project activities.
In addition, the MuIS practices had outreach visits
(before including patients) by primary care physiothera-
pists who were specially trained to convey the content of
the LBP guidelines to GPs [9]. During the study, the
MuIS practices were offered follow-up contacts with the
outreach visitor. After each practice contact, the out-
reach visitor registered which topics had been discussed
and the duration of the contact. The MuIS practices
were also offered quality reports to reflect upon their
treatment of LBP (e.g. how many patients they referred
and how often they made new appointments for patients
with LBP) and risk stratification tools integrated into the
electronic medical record system (STarT Back Tool and
screening questions regarding psycho-social risk factors)
[9]. The STarT Back Tool subgroups patients according
to prognosis and guides treatment pathways [11]. How-
ever, the physiotherapists that the GPs could refer to
were not offered any special training programme for this
study, i.e. they did not receive the training programme
as delivered in the British randomised STarT Back Trial
[11]. GPs in the MuIS group had the STarT Back Tool
embedded into a pop-up in their electronic medical rec-
ord system and could use the STarT Back Tool to guide
treatment as well as give this information to the physio-
therapists when referring a patient. Additional questions
in the pop-up addressed psycho-social barriers to recov-
ery, such as pending claims or work-related problems
[9]. These risk stratification tools could be used at the
initial consultation or be used if the patient had not im-
proved after 2 weeks with LBP.
All patients (regardless of allocation group) were in-
vited to fill in a questionnaire at home after the initial
consultation. They could either complete questionnaires
on the Internet or fill in and return paper versions. The
questionnaires were typically filled in on the date of inclu-
sion. The questionnaire included the STarT Back Tool
and other patient-reported outcomes (see the “Clinical
outcomes” section). This information was collected by the
researchers and no information or feedback regarding the
patients’ self-reported STarT Back questionnaire and the
other patient-reported outcomes were given to the GP.
Follow-up questionnaires were sent to the patient after
4, 8, and 52 weeks; in case of no response, a reminder
was sent after 14 days. If a patient was seen again in
general practice due to a LBP diagnosis within 3 months
after inclusion, the pop-up appeared again and the GP
was thereby prompted to fill in further information
about the patient [9].
GPs in the PaIS group received incentives of 1500
DKK (~£150), and GPs in the MuIS group received 2500
DKK (~£250) for study participation. This covered
downloading and installing software to restructure their
electronic medical records, for time spent including pa-
tients, for receiving outreach visits, and for the on-going
contact with the outreach visitors. Participating practices
were contacted once every fortnight to remind them of
patient inclusion. Reminders were given in the form of
emails, as postal letters, in newsletters for GPs on the
internet, or in local newspaper articles. On a few occa-
sions, the reminder included a friendly remark on remem-
bering to include patients but in most cases, the practices
were just informed about the study and thanked for
their participation. The North Denmark Region’s ad-
ministration provided data for the primary outcome,
which included referrals to Danish hospitals for LBP and
data on healthcare utilisation and unit costs (Additional
file 1). Questionnaire data were kept and merged by an ex-
ternal data manager at the North Denmark Region’s De-
partment of Information Technology. Data were merged
using the unique personal identification number assigned
to all Danish citizens.
Clinical outcomes
Primary and secondary outcomes pertained to the pa-
tient. The primary outcome was the referral of patients
to secondary healthcare within 12 weeks with an LBP
code (ICD10 codes DM 40–43, DM 45–49, DM 51, DM
53–54, DM 95–96, and DM 99). Post hoc, it was decided
to run a sensitivity analysis with follow-up after 8, 16,
and 52 weeks. Secondary outcomes were assessed using
patient-reported questionnaires after 4, 8, and 52 weeks.
The secondary outcomes were employment status (y/n);
sick leave within the last 28 days (y/n) measured after 4
and 8 weeks; sick leave within the last 14 days (y/n)
measured after 52 weeks; satisfaction with the received
treatment, which was categorised on a visual analogue
scale (VAS) in two groups (0–5 or 6–10, higher score in-
dicating more satisfaction); and satisfaction with the
treatment outcome, which was categorised on a VAS in
two groups (0–5 or 6–10, higher score indicating more
satisfaction). The questions regarding satisfaction were
formulated as “To what extent are you satisfied with the
treatment you have received for your back problems?”
and “To what extent are you satisfied with the results
from your back treatment?” Patients responded by select-
ing from 11-point numerical rating scales. The scales
were labelled at 0 (highly unsatisfied) and at 10 (highly
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satisfied). Other secondary outcomes were functional dis-
ability, assessed by the Roland Morris Disability Question-
naire (RMDQ) [12] (Patrick version, scale 0–23 points,
higher scores indicating more disability); back pain inten-
sity assessed by a numerical rating scale (0–10 points,
higher scores indicating more intense pain); and general
health assessed by the EuroQol visual analogue scale
(EQ VAS; 0–100 points, higher score indicating a higher
self-rated general health). The combined set of primary
and secondary outcomes is in line with recommendations
for a core set of outcomes in LBP studies [13].
The data we collected via pop-ups were stored in a
national database for general practice. This included re-
ferrals registered by the GPs, duration of pain, GPs’ as-
sessment of improvement in patients’ symptoms, as
well as tertiary outcomes which included a description
of how many patients were scored with The STarT Back
Tool by the GPs, how often the GPs assessed their qual-
ity report, and a process evaluation (tertiary outcome) of
GPs’ skills, beliefs, and behaviours and the patients’ beliefs
and behaviours [9]. The national database closed due to
legal issues and data collected via pop-ups were lost.
Therefore, the primary outcome was assessed using data
on referrals provided by the North Denmark Region’s
administration. Data on pain duration were, however,
lost together with data on tertiary outcomes [9]. This shift
in the data source for the primary outcome was made dur-
ing the recruitment stage and while the assessors were still
blinded.
Cost-effectiveness analysis
Alongside this cluster randomised controlled trial, an
economic evaluation was conducted to assess whether it
was cost effective to implement the MuIS. Costs collected
from a healthcare sector perspective and the probability of
not being referred to secondary care within 12 weeks were
used as outcome measures in a cost-effectiveness analysis.
The evaluation was carried out as a within-trial assessment
with a 12-week time horizon [14]. The Danish National
Health Insurance Service Register, the Danish National Pa-
tient Register, and the Danish National Prescription Regis-
try provided individual level data on resource utilisation
and unit costs (Additional file 1). The following costs were
included: primary and secondary healthcare costs, publicly
subsidised costs of medicine, and intervention costs [15].
Costs were adjusted for differential timing using the con-
sumer price index provided by Statistics Denmark and pre-
sented in British pounds (£) for the year 2015.
The base case analysis considered costs and effects ad-
justed for patients’ age, patients’ sex, and practice size.
Costs were furthermore adjusted for baseline healthcare
costs within 12 months prior to inclusion. A generalised
linear model with a gamma family was applied for the
cost regression, while a logistic regression was applied
for the effectiveness measure. For the base case analysis,
a probabilistic sensitivity analysis with 5000 bootstrap
replications was conducted and this illustrates the com-
bined uncertainty around the decision to adopt the
MuIS (Fig. 2). The unadjusted results are presented in a
scenario analysis.
Statistical analysis
A power calculation was performed to detect a between-
group difference of 5 % in referrals to secondary health-
care within 12 weeks—13 % in the MuIS group and 18 %
in the PaIS group. We expected to recruit 100 practices
with an unequal cluster size [9]. The sample size was esti-
mated with 90 % power and a 5 % level of confidence.
Based on a conservative estimate of a likely cluster effect
of 16 %, we needed to include 2700 patients [9]. The re-
cruitment coincided with a conflict between the Danish
regions and the Organization of General Practitioners in
Denmark, and this was likely to have affected GPs’ willing-
ness to participate. Consequently, after 15 months, it was
decided to accept the inclusion of 60 practices. This deci-
sion was made before data on the primary outcome were
collected and while the assessors remained blinded. De-
scriptive statistics included the number (%) for categorical
variables and mean (SD) or median (IQRs) for continuous
variables, depending on the distribution of the variable.
However, costs are presented as means (SD) even though
distribution of costs was right skewed (Additional file 1).
Differences in baseline characteristics between the two
study groups were analysed using Fisher’s exact test for
categorical variables and the two-sample t test or the
Mann-Whitney U test for continuous variables. For the
primary outcome (referral to secondary healthcare) and
the secondary binary outcomes (employment status, sick
leave, satisfaction with received treatment, and satisfaction
with treatment outcome), the odds ratios between the two
groups were estimated using a generalised estimating
equation (GEE) model with logit link and an interchange-
able correlation to model the within-practice correlation.
The continuous outcomes (RDMQ, back pain intensity,
and EQ VAS) were analysed using linear mixed effects
models with groups and weeks from baseline as fixed ef-
fects and patients within practices as nested random ef-
fects. The fixed effects were modelled as an interaction
term between the groups and weeks from baseline. Results
were presented unadjusted and adjusted for patients’ age
(restricted cubic spline), sex (binary), and practice size (re-
stricted cubic spline) [16]. Using the method described by
Wu et al., the within-cluster correlation for the primary
outcome was estimated by an intra-class correlation coef-
ficient [17]. An approximate confidence interval (CI) for
the intra-class correlation coefficient was estimated by
1000 bootstrap replications. Throughout the analyses,
95 % CIs were reported, and a p value of <0.05 was
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considered statistically significant. Analyses were per-
formed by the intention-to-treat principle and followed
the CONSORT 2010 statement for analysing cluster ran-
domised trials [18]. Analyses were performed using Stata
(IC version 13.1) (College Station, TX, USA). This study
was registered at ClinicalTrials.gov (registration number:
NCT01699256).
Results
Practices were enrolled between January 22, 2013 and
March 15, 2014, and recruited patients until June 30,
2014 with a subsequent 1-year follow-up until June 29,
2015. Of the 60 general practices recruited, 28 were ran-
domised to the MuIS group and 32 were randomised to
the PaIS group (Table 1). Six practices that did not in-
clude patients were lost to follow-up. Fifty-four (90 %)
practices (28 MuIS, 26 PaIS) included a total of 1101 pa-
tients (Fig. 1). Follow-up data for the primary outcome
were available for 1101 (100 %) of the patients. Patients
had an average age of 43 (SD 12.0) years, and 550 (49.8 %)
patients were women (Table 1). Twenty-seven patients
(5.0 %) in the MuIS group were referred to secondary care
within 12 weeks vs. 59 patients (10.5 %) in the PaIS group
(OR 0.52, 95 % CI 0.29 to 0.93; p = 0.027). The estimate
was similar when adjusting for patients’ age, patients’
sex, and practice size (AOR 0.52, 95 % CI 0.30 to 0.90;
p = 0.020) (Table 2). In a sensitivity analysis of the pri-
mary outcome with follow-ups after 8, 16, and 52 weeks,
the estimates were not significantly changed. The intra-
class correlation for the primary outcome was 0.015
(95 % CIapproximate 0.011 to 0.069). There were no sta-
tistically significant differences in effect on employment
status, sick leave, functional status, and EQ VAS be-
tween the two groups, but patients in the PaIS group
were significantly more satisfied with the treatment
outcome than patients in the MuIS group (Table 2). In
a base case analysis, the MuIS dominated the PaIS with
higher effects achieved at a lower cost of £−52.47 (95 %
CI −141.24 to 36.30). The probabilistic sensitivity ana-
lysis confirmed the dominance of the MuIS (Fig. 2).
The scenario analysis also found the MuIS to be dom-
inant with a cost saving of £−93.20 (95 % CI −198.38 to
11.99 per patient). Details of the healthcare utilisation
and costs are provided in Additional file 1. As part of
the intervention, all practices in the MuIS group had at
least one outreach visit with a median duration of
60 min [IQR 60 to 76.25]; the median time spent on
follow-up (visits or phone calls) was 60 min [IQR 37.5
Table 1 Baseline characteristics
MuIS group PaIS group
(N = 28 practices, n = 539 patients) (N = 32 practices, n = 562 patients)
Practice characteristics
Practice size (number of listed patients) 1883 [IQR 1602 to 3475] 2086 [IQR 1649 to 3876]
Medical outreach visit in 2011 (yes) 20 (71.4 %) 22 (68.8 %)
Referral rate in 2011 (‰)a 4.4 [IQR 3.0 to 6.0] 4.9 [IQR 3.9 to 6.5]
Patient characteristics
Age (years)b 43.8 (11.8) 42.6 (12.1)
Sex (male)b 282 (52.3 %) 272 (48.1 %)
Education at college level or more (yes)c 58 (27.2 %) 53 (21.4 %)
Co-morbidity (yes)c 85 (39.9 %) 86 (35.5 %)
Employed or self-employed (yes)c 159 (74.0 %) 187 (75.1 %)
Sick leave, LBP-related during the last 2 weeks (yes)c 100 (56.2 %) 118 (54.4 %)
Roland Morris Disability Questionnaire (0–23 points)c 14.2 (5.5) 13.0 (5.8)
Back pain intensity (0–10 points)c 6.2 (2.1) 6.1 (2.2)
EQ VAS (0–100 points)c 54.4 (22.8) 55.6 (22.4)
STarT Back Tool score (low risk)c 51 (25.0 %) 73 (30.8 %)
STarT Back Tool score (medium risk)c 89 (43.6 %) 87 (36.7 %)
STarT Back Tool score (high risk)c 64 (31.4 %) 77 (32.5 %)
Data are presented as the median [IQR], mean (SD), or n (%)
aReferral rate to secondary healthcare is calculated by the total number of listed patients in the practice (including patients without back pain) divided by the
number of these patients referred to secondary healthcare with a back diagnosis in 2011
bBaseline data collected by the GP at the initial consultation. Information regarding age and sex was available in 1101 (100 %) patients, representing 54 (90.0 %)
of the included practices
cData collected via questionnaires after the initial consultation (n = 475, representing 50 practices). Complete data was available for baseline characteristics for
practices. However, completeness for the patient reported measures varied education level (n = 461), co-morbidity (n = 455), employment status (n = 464), sick
leave (n = 395), Roland Morris Disability score (n = 406), back pain intensity (n = 457), EQ-5D VAS (n = 466), and STarT Back Tool (n = 441)
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to 60]. At every initial visit, practices were represented
by GPs, and in five cases (17.9 %), GP trainees also par-
ticipated. Discussions about the clinical examination,
triage, coding of patients with LBP, general advice, im-
portance of making follow-up appointments, the STarT
Back Tool, questions regarding psycho-social risk fac-
tors, referral in primary healthcare, and the handing-
out of written material were undertaken at 28 initial
visits (100 %). Discussions regarding patient history and
referrals to secondary healthcare were undertaken at 27
(96.4 %) of the initial visits, and instructions on the use
of the computer programme were provided at 13
(46.4 %) of the initial visits. When comparing partici-
pating practices and non-participating practices in the
North Denmark Region prior to this study (October
2011), we found that a similar proportion of patients in
these practices were referred to secondary care with
back-specific diagnoses (4.9‰ IQR 3.88 to 6.48 vs. 5.2
‰ IQR 3.10 to 6.97, p = 0.818). Moreover, participating
and non-participating practices were of a similar size
(median 2061.5 patients [IQR 1636 to 3876] vs. 2227
patients [1642 to 3888], p = 0.957). Among participating
practices, 42 (70 %) had a medical outreach visit from
the Quality Unit for General Practice in the North
Denmark Region in 2011 compared with 72 (55 %)
among non-participating practices (p = 0.057).
Discussion
The MuIS changed general practice referral behaviour
compared to the PaIS.
We used a combination of outcomes recommended
for studies on LBP [13]. The patient-reported outcomes
were validated measures, whereas questions regarding
satisfaction with the received treatment and satisfaction
with treatment outcomes were formulated to fit our set-
ting. The fact that referrals to secondary healthcare could
be assessed by registry data allowed a 100 % follow-up rate
of the included patients for the primary outcome and for
Assessed for eligibility (191 practices)
Reasons for not participating:
Did not accept participation (127 practices)
Participated in test activities    (2 practices)
Accepted after deadline              (1 practice)
Had no data capture module      (1 practice)
Allocated to receive the passive implementation strategy
(32 practices)
Did not receive allocated intervention
(0 practices)
Allocated to receive the multifaceted implementation strategy
(28 practices)
Did not receive allocated intervention
(0 practices)
Reasons for exclusion:
Age > 65 years (n=23)
Age < 18 years (n=1)
Did not include patients (0 practices)
28 practices included a median of 13.5 patients [IQR 4.0 - 23.5]
Analysed(28 practices and 539 patients)
Median of 13.5 patients [ IQR 4.0 - 23.5]
Did not assess patients (0 practices)
28 practices assessed 563 patients, median of
14.0 patients [ IQR 4.0 - 25.25]
Reasons for exclusion:
Age > 65 years (n=24)
Age < 18 years (n=1)
Pregnancy (n=2)
Did not include patients (1 practice)
27 practices included a median of 16.0 patients [IQR 9.5 - 31.75]
Analysed(26 practices and 562 patients)
Median of 16.0 patients [ IQR 9.5 - 31.75]
Did not assess patients (5 practices)
27 practices assessed 589 patients, median of
17.0 patients [ IQR 11.0-34.25]
Fig. 1 Flowchart. Sixty general practices were included in the study. A total of 55 practices (28 MuIS, 27 PaIS) assigned 1152 patients (566 MuIS,
586 PaIS) for assessment of eligibility. Fifty-four practices (28 MuIS, 26 PaIS) included and contributed with 1101 patients to the analysis for the
primary outcome
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the cost-effectiveness analysis. The change in data source
for the primary outcome is a limitation. Use of registry
data might have introduced uncertainty in the estimates
due to difference in registration practices among different
hospital departments, varying completeness of registra-
tion, as well as by changes in registration practice over
time. However, we found it unlikely that this should have
affected the two allocation groups unevenly in our study.
Hence, we did not expect bias to be introduced by the
change in data source. This study was powered to recruit
2700 patients from 100 practices. The recruitment for this
project unfortunately coincided with a conflict between
the Danish regions and the Organization of General Prac-
titioners in Denmark, and this affected GPs’ willingness to
participate. Consequently, after 15 months, the inclusion
of 60 practices and approximately 1200 patients was ac-
cepted. This decision was made while assessors were still
blinded and before registry data were collected. We con-
sider the risk of bias caused by a smaller sample very un-
likely given the large effect size (5.0 vs. 10.5 %). However,
Table 2 Results
MuIS groupa PaIS groupa ORb p value AORb p value
Referral to secondary healthcare (y)
After 12 weeks 27 (5.0 %) 59 (10.5 %) 0.52 (0.29 to 0.93) 0.027 0.52 (0.30 to 0.90) 0.020
Employment status (y)
After 4 weeks 113 (74.8 %) 117 (73.1 %) 1.18 (0.67 to 2.08) 0.563 1.26 (0.71 to 2.24) 0.424
After 8 weeks 111 (77.1 %) 124 (72.1 %) 1.36 (0.76 to 2.43) 0.297 1.42 (0.89 to 2.26) 0.141
After 52 weeks 101 (71.1 %) 109 (71.2 %) 1.02 (0.60 to 1.74) 0.947 0.95 (0.55 to 1.63) 0.850
Sick leave within 14 days (y)
After 4 weeks 54 (42.9 %) 60 (46.2 %) 0.87 (0.55 to 1.40) 0.577 0.90 (0.57 to 1.43) 0.658
After 8 weeks 32 (25.4 %) 43 (29.5 %) 0.82 (0.44 to 1.53) 0.533 0.84 (0.44 to 1.61) 0.605
After 52 weeks 17 (13.7 %) 19 (14.8 %) 1.00 (0.59 to 1.73) 0.981 0.97 (0.52 to 1.82) 0.922
Satisfaction with received treatment (y)
After 4 weeks 83 (56.5 %) 99 (64.3 %) 0.72 (0.48 to 1.07) 0.105 0.75 (0.53 to 1.07) 0.112
After 8 weeks 81 (57.9 %) 114 (68.3 %) 0.64 (0.41 to 0.99) 0.046 0.66 (0.43 to 1.02) 0.061
After 52 weeks 85 (57.8 %) 105 (68.6 %) 0.62 (0.39 to 0.98) 0.040 0.61 (0.39 to 0.95) 0.029
Satisfaction with treatment outcome (y)
After 4 weeks 71 (48.3 %) 82 (56.2 %) 0.68 (0.47 to 0.98) 0.037 0.72 (0.51 to 1.00) 0.050
After 8 weeks 69 (49.3 %) 98 (60.1 %) 0.64 (0.39 to 1.04) 0.073 0.66 (0.42 to 1.05) 0.081
After 52 weeks 75 (51.0 %) 102 (67.1 %) 0.51 (0.32 to 0.84) 0.007 0.50 (0.31 to 0.81) 0.004
RMDQ (0–23 points) Unadjusted difference Adjusted difference
Dif 4 weeks—baseline −4.23 −2.81 −1.42 (−2.88 to 0.39) 0.056 −1.34 (2.77 to 0.09) 0.067
Dif 8 weeks—baseline −5.73 −4.59 −1.14 (−2.59 to 0.30) 0.121 −1.26 (−2.68 to 0.16) 0.083
Dif 52 weeks—baseline −7.16 −6.50 −0.67 (−2.13 to 0.80) 0.373 −0.74 (−2.18 to 0.70) 0.316
Back pain intensity (0–10 points)
Dif 4 weeks—baseline −1.96 −1.54 −0.42 (−1.02 to 0.19) 0.176 −0.53 (−1.12 to 0.69) 0.083
Dif 8 weeks—baseline −2.29 −2.31 0.03 (−0.57 to 0.63) 0.931 0.01 (−0.57 to 0.60) 0.972
Dif 52 weeks—baseline −2.43 −2.77 0.33 (−0.27 to 0.93) 0.282 0.29 (−0.30 to 0.89) 0.328
EQ VAS (0–100 points)
Dif 4 weeks—baseline 10.57 8.78 1.79 (−4.13 to 7.71) 0.553 2.96 (−2.51 to 8.43) 0.288
Dif 8 weeks—baseline 15.90 13.84 2.06 (−3.83 to 7.95) 0.493 2.46 (−2.95 to 7.87) 0.374
Dif 52 weeks—baseline 15.46 14.89 0.58 (−5.34 to 6.50) 0.848 1.25 (−4.20 to 6.70) 0.653
The primary outcome (referral to secondary healthcare) was measured after 12 weeks and was collected from registries with a 100 % follow-up rate, representing
54 practices. The intra-class correlation for the primary outcome was 0.015 (95 % CIapproximate 0.011 to 0.069). The secondary outcomes (employment status, sick
leave, satisfaction with received treatment, satisfaction with treatment results, Roland Morris Disability Questionnaire (RMDQ), back pain measured by numerical
pain rating [back pain intensity], and EuroQol VAS (EQ VAS)) were measured after 4, 8, and 52 weeks. All secondary outcomes were collected from patient
questionnaires. A total of 475 patients, representing 50 (83.3 %) practices, participated in the questionnaires
aData are number (%) or differences (follow-up—baseline)
bData are unadjusted odds ratios (OR 95 % CI), adjusted odds ratios (AOR 95 % CI), unadjusted mean differences (95 % CI), or adjusted mean differences (95 % CI).
Adjustments are made for patients’ age, patients’ sex, and practice size
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generalisability might be reduced. The response rate for
the secondary outcomes was low, and with responders
representing 50 (83.3 %) of the practices, this may harm
the validity of the secondary outcomes. The probability of
referral from primary care to secondary care within
12 weeks was used as an effectiveness measure in the
cost-effectiveness analysis. It is a limitation in the eco-
nomic evaluation. This might be considered double count-
ing as costs related to primary and secondary healthcare
services are included in the denominator of the incremen-
tal cost-effectiveness ratio. A more appropriate effective-
ness measure could be QALYs. By participating in this
study, the included practices agreed to receive the interven-
tion, which included an outreach visit while other practices
might have declined participation because of resistance to
elements within the MuIS. Subsequently, practices partici-
pating in the study were generally more likely to have had
an outreach visit from the regional quality unit the year
prior to the study compared with the non-participating
practices. This might imply that the participating practices
were more likely to work with quality improvement com-
pared with non-participants.
Reviews did not offer compelling evidence for the super-
iority of multifaceted interventions compared to single-
component interventions [19]. Several randomised con-
trolled trials have studied the implementation of LBP
clinical guidelines in general practice using different
strategies [20, 24]. The use of physiotherapists as facili-
tators in general practice was novel in our study. A pre-
vious randomised study used outreach visits to raise the
awareness of LBP guidelines in 24 centres with 2187
patients, but the management of patients was mostly
unchanged by those outreach visits [20]. In another large
cluster randomised controlled trial with 118 general
practices and 1378 patients, the effect of two multifaceted
implementation strategies was compared to a postal dis-
semination of guidelines. No effect on patients’ functional
levels was found when using an implementation strategy
including four basic education modules and flyers for pa-
tients versus postal dissemination of the guidelines. When
adding motivational counselling to patients (each patient
had up to three sessions of 10–15 min), a small signifi-
cant difference was found in patients’ functional level,
measured by the 12-item Hannover Functional Ability
Questionnaire [21]. As with our study, these two stud-
ies included outreach visits at GPs’ work environments,
which, in our setting, typically took place during an ex-
tended lunch break. This may have contributed to a re-
laxed and informal learning environment. Other studies
have used workshops to implement LBP guidelines. A
Dutch guideline implementation study with 67 GPs and
531 patients included a 2-h educational and clinical
practice workshop in addition to a screening tool for
patients with LBP and a tool for patient education. The
intervention succeeded in reducing referrals from gen-
eral practice to therapists (physical, exercise, or manual
therapists) [22]. In the IMPLEMENT study, the researchers
found a change in clinician behaviour (knowledge, atti-
tudes, and intentions) among 92 general practices offering
two facilitated interactive workshops in a total of 6 h with
the purpose of decreasing X-ray referrals and increasing
advice to stay active [23]. However, the change in behav-
ioural attitude was not reflected in a difference in the ac-
tual referral rate to X-ray or CT-scan amongst GPs
receiving the intervention compared with GPs receiving
the usual dissemination strategy (access to guidelines) [23].
An additional study with 462 GPs and their LBP patients
with accepted compensation claims were unsuccessful in
improving concordance with Canadian LBP guideline
recommendations. The intervention consisted of a pas-
sive knowledge transfer method that involved postal
letters with guidelines and reminders [24]. In contrast,
a successful intervention included a clinical decision
support system as part of a multifaceted strategy, to-
gether with quality reports and peer-to-peer consulta-
tions in a large cohort study with 1200 GPs and 23,685
patients. This multifaceted strategy was found effective
in reducing MRI referrals from 5.3 to 3.7 % [25]. Our
study likewise found a high effect size in the rate of refer-
ral following a broad MuIS that included clinical decision
support, feedback (statistics regarding LBP patients), and
outreach visits. Compared with the other trials aimed at
GPs, our intervention dose (consultation time with clini-
cians) was slightly below average. GPs in the MuIS group
could use the STarT Back Tool to categorise patients into
(i) low risk patients, where advice and information can
stand alone, (ii) medium risk patients with extra needs
for exercise treatment or manual therapy and who may
Fig. 2 Probabilistic sensitivity analysis. A probabilistic sensitivity
analysis with 5000 bootstrap replications confirms that the MuIS is
cost effective compared to the PaIS. The effects are calculated as
the probability of not being referred in the MuIS group minus the
probability of not being referred in the PaIS group
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benefit from a referral to physiotherapy or chiropractic
treatment, or (iii) high risk patients with an additional
need for addressing psycho-social barriers for recovery.
This tool has been found both effective and cost effect-
ive as a tool for subgrouping LBP patients and targeting
their treatment [11, 26]. The STarT Back Tool is now
widely used, and as of November, 2015, it has been
translated into Danish and 20 other languages [27, 28].
The STarT Back Tool was known by many physiothera-
pists in Denmark and was described in the Regional
LBP guideline. However, training in the stratified care
management programme developed at Keele University
was not generally available in Denmark. Hence, to our
knowledge, none of the Regions’ GPs or physiotherapists
had been trained in the stratified management programme
from Keele University. The GPs’ and physiotherapists’
knowledge about the STarT Back Tool has been adapted
from scientific journals, from discussions with colleagues,
at conferences, from the regional LBP guidelines, and,
probably most importantly, from the outreach visits at the
MuIS practices. In addition to the STarT Back Tool, GPs
in the MuIS group had additional questions regarding
psycho-social risk factors built into their electronic
medical record system regarding work problems, com-
pensation claims, and psychological or social barriers to
recovery. The tools available to the GPs may be viewed
in the context of the coloured flags [3]. In combination,
the STarT Back Tool and the questions about psycho-
social risk factors incorporate biological, psychological,
and social aspects. Patients with red flags (serious path-
ology) were excluded from our study. Yellow flags (beliefs,
emotional responses, and pain behaviour) were addressed
by the STarT Back Tool. Blue flags (perceptions about
the relationship between work and health), black flags
(rehabilitation/compensation system or contextual obsta-
cles, such as legislation and injury claim conflicts), and or-
ange flags (psychiatric factors) were encompassed by the
additional questions regarding psycho-social problems.
Satisfaction was planned to be analysed as a continuous
variable but a non-parametric distribution of data led us
to dichotomise the two satisfaction variables and this may
have led to loss of information regarding satisfaction. We
found a reduced satisfaction among patients in the MuIS
group. This discrepancy between functional outcome
measures and patients’ satisfaction has also been reported
by Takeyachi et al. [29]. We do not know why patients in
the MuIS group were more dissatisfied than patients in
the PaIS group. One reason could be GPs advice to stay
active regardless of patients’ pain, or that patients with
low risk were recommended minimum treatment, or it
could be related to unfulfilled expectations induced by
GPs’ information of an expected good prognosis.
Our study adds the following new knowledge to existing
literature: a multifaceted implementation strategy can
significantly change the referral behaviour to secondary
healthcare, be cost effective, without decreasing the qual-
ity of patient care. However, patients’ preferences may not
necessarily support this. In the UK and many other coun-
tries, LBP is a leading healthcare burden [1, 30]. There-
fore, these findings may have widespread importance for
primary healthcare and policymakers.
More research into the types and doses of interventions
is needed to optimise strategies for changing clinical be-
haviour in the future. The field of implementation science
is evolving with an increasing number of possible imple-
mentation tools [5]. Passive implementation strategies,
such as simply distributing a guideline might have an ef-
fect on some circumstances, and multifaceted strategies
are not always superior to single-component strategies
[19]. However, actively involving GPs and including a suf-
ficient variety of components in the multifaceted strategy
can change behaviour in general practice.
Conclusions
The MuIS reduced the 12-week referral to secondary
healthcare from 59 (10.5 %) to 27 (5.0 %) and was cost
effective compared with the PaIS. The MuIS did not sig-
nificantly change patients’ functional levels, pain levels,
or self-rated health compared with the PaIS. However,
patients’ satisfaction with their treatment and treatment
outcomes was significantly less.
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